Microarray-based identification of differentially expressed genes in extramammary Paget's disease

Area of Science:

• Oncology
• Genetics
• Dermatology

Background:

• Extramammary Paget's disease (EMPD) is a rare cancer, making its molecular basis poorly understood.
• Understanding gene expression in EMPD is crucial for diagnosis and treatment.
• Scrotal EMPD presents unique challenges due to its rarity.

Purpose of the Study:

• To identify differentially expressed genes in scrotal EMPD using microarray analysis.
• To elucidate the molecular mechanisms underlying EMPD development.
• To validate key gene expression findings through real-time PCR and immunohistochemistry.

Main Methods:

• Microarray analysis comparing 6 EMPD tissue samples with 6 normal scrotal epithelium samples.
• Agilent single-channel microarray platform utilized for gene expression profiling.
• Real-time PCR and immunohistochemistry employed for validation of selected genes, including PRLR.

Main Results:

• Identified 799 up-regulated and 723 down-regulated genes in EMPD tissues.
• Confirmed significant overexpression of ERBB4, PRLR, TCF3, PIK3R3, SULT1A1, and TCF7L1 in EMPD via real-time PCR.
• Immunohistochemistry validated the overexpression of prolactin receptor (PRLR) in EMPD.

Conclusions:

• Microarray analysis successfully identified key genes associated with EMPD.
• The identified differentially expressed genes are strongly linked to the occurrence of EMPD.
• Further research into these genes may offer novel therapeutic targets for EMPD.